ELDN (Eledon Pharmaceuticals) Insider Ownership: 1.24 % (As of Aug. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ELDN Eledon Pharmaceuticals Inc ELDN
26 GF Score
Price $3.54
! 1 Warning Sign
View Full Analysis

What is Eledon Pharmaceuticals Insider Ownership?

Eledon Pharmaceuticals ELDN -2.07% 26 Insider Ownership is 1.24 % as of Aug. 19, 2026. GuruFocus rates ELDN with a GF Score™ of 26/100. The stock has 1 warning sign investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Eledon Pharmaceuticals's insider ownership is 1.24%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Eledon Pharmaceuticals's Institutional Ownership is 54.84%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Eledon Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 99.98%.

Eledon Pharmaceuticals Insider Ownership Historical Data

* Premium members only.

The historical data trend for Eledon Pharmaceuticals's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eledon Pharmaceuticals Insider Ownership Chart

Eledon Pharmaceuticals Historical Data

The historical data trend for Eledon Pharmaceuticals can be seen below:

2025-07-31 2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28 2026-05-31 2026-06-30 2026-07-31
Insider Ownership 1.57 1.57 1.57 1.57 1.26 1.27 1.27 1.24 1.24 1.24
ELDN
26GF Score
Eledon Pharmaceuticals Inc ELDN
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eledon Pharmaceuticals Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 1.24 % mean?
Eledon Pharmaceuticals (ELDN) has a Insider Ownership of 1.24 % as of Aug. 19, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Eledon Pharmaceuticals and its competitors.
Is Eledon Pharmaceuticals' Insider Ownership too high?
Eledon Pharmaceuticals' current Insider Ownership is 1.24 %. Overall, Eledon Pharmaceuticals has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Eledon Pharmaceuticals' Insider Ownership compare to NMRA and ALXO?
Eledon Pharmaceuticals' Insider Ownership of 1.24 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Eledon Pharmaceuticals and its competitors. Eledon Pharmaceuticals's current Insider Ownership is 1.24 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eledon Pharmaceuticals stock overvalued right now?
Eledon Pharmaceuticals (ELDN) has a current Insider Ownership of 1.24 %. The current Insider Ownership is 1.24 %. Eledon Pharmaceuticals' overall GF Score™ is 26/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Eledon Pharmaceuticals (ELDN), the current Insider Ownership is 1.24 % as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Eledon Pharmaceuticals Business Description

Other Exchanges 2TK:Germany
Address 19800 MacArthur Boulevard, Suite 250, Irvine, CA, USA, 92612
Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.
26GF Score

Get the complete analysis for ELDN

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.54
Price